View Single Post
Old 06-11-2014, 06:32 PM
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default

On the substantive issue.

UCSF publish their DBS results [1]

"For bilateral DBS, the evaluations showed a 45-70% improvement in the scores on standard rating scales, off of medication, as a result of DBS. This is similar to the results from other major centers and represents a major improvement in mobility. In our series, the risk of stroke is 1.6%, the risk of severe stroke with death or permanent major disability is 0.5%, and the risk of device infection that requires further surgery for device removal is 4%."

Note that the 45-70% improvement is relative to the off state. It would be useful to have the figure relative to the prior, medicated on state as well.

I suspect that even if we agree on the accuracy of the figures, different people will react to them differently.

Reference

[1] http://neurosurgery.ucsf.edu/index.p...html#candidate

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
anagirl (06-11-2014), bluedahlia (06-12-2014), lab rat (06-11-2014), Tupelo3 (06-11-2014)